HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre
Year: 2025
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Sexually transmitted hepatitis C virus (HCV) infection is widely reported in urban cohorts of HIV-positive men who have sex with men (MSM), with less data on HIV-negative MSM. High HCV incidence has been reported in cohorts of HIV-negative MSM using HIV pre-exposure prophylaxis (PrEP), but no previous studies have systematically offered HCV screening to PrEP users and non-PrEP users. METHODS: We offered point-of-care serology and/or PCR HCV screening to HIV-negative MSM and transgender women (TW) attending a peer-led community sexual health centre in Barcelona, Spain. We estimated HCV prevalence ratios using log-binomial models of sexual and drug-use behaviors and conducted descriptive analyses linking infection, PrEP use, and behavior patterns. The trial was registered with ClinicalTrials.gov (NCT06847958). FINDINGS: HCV screening was provided to 13,089 HIV-negative MSM and TW, including 3039 (23·1 %) current PrEP users. HCV prevalence was similar in PrEP users (0·10 %, 3/3039) and non-PrEP users (0·12 %, 12/10,122). We identified one case of acute infection; no HCV cases were identified among TW. HCV infection was associated with several behaviours including slamming, group sex, sharing syringes, fisting, and using drugs related to chemsex. INTERPRETATION: We found a relatively low prevalence of active HCV, and only one case of acute infection, among HIV-negative MSM and TW attending a community centre. At a descriptive level, HCV-infected PrEP and non-PrEP users show markedly higher risk behaviors than PrEP and non-PrEP users without HCV, yet low prevalence render these findings exploratory and warrants larger analytic studies. FUNDING: Gilead Sciences.
Authors: Àngel Rivero, Albert Dalmau-Bueno, Félix Pérez, P. Coll, José M. Cabrera, Mariusz Łucejko, Javier Fernandez, Joan Reguant, Jorge Calderon, Jaume Romero, Federico Caballero, Giovanni Marazzi, Carlos Oro, Daniel Michael Jacobs, Horacio Vicioso, Lisandro Moises, Héctor Taboada, Jorge Saz, Ferran Pujol, Michael Meulbroek, Roger Paredes
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,310
Funder: Gilead Sciences
OpenAlex ID: W4416998805
